Skip to main content

Home

Home

AMRH Site Header Menu

  • Home
  • Who We Are
  • Our Focus
    • African Medicines Agency
    • AMRH Technical Committees
      • ABRF TC
      • AVAREF-TC
      • AMDF-TC
      • AMQF
      • IMS-TC
      • EMP-TC
      • GMP TC
      • MPRR-TC
      • RCD-TC
    • RCOREs
    • AMRH Partnership Platform
  • What We Do
  • Resources
    • FRPath® Project.
SEARCH BY
AMRH Partnership Platform (AMRH PP)
  • About AMRH Partnership Platform (AMRH PP)
  • Purpose and objectives of AMRH Partnership Platform
  • Scope
  • Members
  • Join Us
  • News and Events

About AMRH Partnership Platform (AMRH PP)

To ensure that Africa's medical products regulatory system works effectively, the AMRH works closely with partners and stakeholders. The AMRH Partnership Platform is the Steering Group for the African chapter of the WHO's global Coalition of Interested Parties (CIP), which aims to effectively manage and coordinate different partners and stakeholders involved in this stream of work around the world, to avoid duplication, ensure optimal utilization of resources and establish consensus on priority areas of intervention.

The AMRH PP provides different cross-cutting stakeholders working to strengthen the regulatory system in Africa with a platform to share their lessons, define collective impact and identify like-minded partners to go along with. It is a multi-stakeholder mechanism with a continent-wide perspective, critical to ensuring that partners can enhance the implementation of AMRH and various regulatory systems strengthening programmes and harmonization initiatives

Purpose and objectives of AMRH Partnership Platform

The AMRH PP aims to increase collaboration among stakeholders supporting regulatory systems development in Africa; foster mutual responsibility, accountability and shared impact; and ultimately minimize duplication and coordinate efforts at all levels of implementation.

The main objective of the AMRH PP is to enhance efficiency and effectiveness in the implementation of the medical products regulatory systems strengthening and harmonization agenda in Africa, through optimal coordination of the different partners and stakeholders providing regulatory support.

The specific objectives of the AMRH PP are to provide technical, financial and policy advocacy support by;

  1. Facilitating effective coordination of partners and resources to ensure alignment and advance the work of the AMRH

  2. Supporting the implementation of Institutional Development Plans (IDP), based on assessment of regulatory capacities using existing tools such as the WHO Global Benchmarking Tool to identify gaps

  3. Providing a forum for review of progress to ensure mutual accountability on implementation of programmes.

Scope

The AMRH PP’s remit is to:

  1. Foster mutual and collective responsibility, alignment and harmonization of efforts in supporting implementation of the regulatory systems strengthening and harmonization agenda across the African Continent.

  2. Facilitate and support adherence to the AU Policy Frameworks and International targets including the Pharmaceutical Manufacturing Plan for Africa (PMPA); Africa Health Strategy (2016-2030), AU Science, Technology, and Innovation Strategy for Africa (2014-2024); Health Research and Innovation Strategy for Africa (HRISA); AU Catalytic framework to end AIDS, TB and Malaria in Africa by 2030; Agenda 2063 and Sustainable Development Goals as they relate to access to medical products and health technologies and the promotion of innovation and industrial development and the elimination of poverty.

  3. Facilitate; i) mutual review of progress, performance and challenges; ii) dialogue on implementation and related capacity and policy issues; and; iii) Peer sharing of lessons and experiences.

Members

New and existing members of the platform include:

 

  1. Africa Centre for Disease Control (A-CDC)

  2. Africa Society for Blood Transfusion (ASBT)

  3. African Society for Laboratory Medicines (ASLM)

  4. Belgian Development Agency (Enabel)

  5. BfArm - Federal Institute for Drugs and Medical Devices, Germany

  6. Bill & Melinda Gates Foundation (BMGF)

  7. Coalion for  Epidemic Preparedness Innovatoin (CEPI)

  8. Centre Humanitaire des Métiers de la Pharmacie (CHMP)

  9. Centre for Innovation in Regulatory Science (CIRS)

  10. Danish Medicines Agency

  11. Drug Information Association (DIA)

  12. Drugs for Neglected Diseases initiative (DNDi)

  13. European & Developing Countries Trials Partnership (EDCTP)

  14. European Directorate for the Quality of Medicines & HealthCare (EDQM)

  15. Establissement Francais de Sang (EFS)

  16. European Commission

  17. European Medicines Agency (EMA)

  18. Family Health International (FHI360)

  19. Global Alliance for Diagnostics (FIND)

  20. French Agency for Development

  21. Gavi The Vaccine Alliance (GAVI)

  22. Deutsche Gesellschaft fuer Internationale Zusammenarbeit (GIZ)

  23. International AIDS Vaccine Initiative (IAVI)

  24. International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)

  25. International Society for Blood Transfusion (ISBT)

  26. Management Sciences for Health (MSH / MTaPS)

  27. PATH

  28. Paul-Ehrlich-Insitut (PEI)

  29. Physikalisch Technische Bundesanstalt (PTB)

  30. Swiss Agency for Development and Cooperation (SDC)

  31. Susan Thompson Buffett Foundation (STBF)

  32. Swissmedic

  33. United Nations Development Programme (UNDP)

  34. UNFPA, Procurement Services Branch, Copenhagen

  35. UNITAID

  36. United States Pharmacopeia (USP)

  37. University of Kwazulu-Natal (UKZN)

  38. Wellcome Trust

  39. WHO and AUDA-NEPAD ( Joint Secretariat)

  40. WHO Collaborating Centre for the Quality Assurance of Medicines (CENQAM)

  41. World Bank

  42. Yolse, Santé Publique & Innovation

Join Us

If your organisation is interested in joining the AMRH PP, please see the membership criteria below and submit an expression of interest.

Membership criteria:

1) Members of AMRH PP are a network of individuals or institutions; or representative of any other legal entity namely; organizations, Companies or Close Corporations that share the same goals, principles and values of jointly advancing the medical product regulatory systems strengthening and harmonization agenda across the African Continent

2) Members shall be drawn from the following groupings; 

Intergovernmental organizations, development partners, funders/donors, pharmaceutical industry represented by regional associations, Civil Society Organizations (CSOs), research and academic institutions, among others. National Medicines Regulatory Authorities (NMRAs) which have attained Maturity Level 3 or above, according to WHO Global Benchmarking Tool (GBT).

3) Members shall have willingness to align and harmonize efforts with like-minded partners in order to avoid duplication and ensure clarity.

4) Members shall have completed an expression of interest form indicating the area of interest, competency and existing expertise will be filled by members intending to join the AMRH Partnership Platform as per form. To join the Platform please ensure your organisation meets the membership criteria  and submit an expression of interest

Link to Application Form

AMRH Site Header Menu

  • Home
  • Who We Are
  • Our Focus
  • What We Do
  • Resources

CONNECT WITH US

Copyright © 2022 African Union Development Agency (AUDA-NEPAD). All rights reserved. | Terms & Conditions | Fraud Alert